Skip to main content

CITADEL ADVISORS LLC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
3,218,810
+1.6% QoQ
Ownership
2.79%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
199,800
PutValue
$0
PutShares
328,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,855,369 across 436 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
40 filing rows on record
Report Date Value (USD) Shares
2026-03-31 199,800
2026-03-31 3,218,810
2026-03-31 328,700
2025-12-31 3,166,642
2025-12-31 93,700
2025-12-31 140,300
2025-09-30 1,589,334
2025-09-30 55,800
2025-09-30 14,200
2025-06-30 89,500
2025-06-30 3,899,011
2025-03-31 132,600
2025-03-31 118,700
2025-03-31 3,907,887
2024-12-31 3,267,779
2024-12-31 197,500
2024-12-31 75,600
2024-09-30 129,400
2024-09-30 3,673,226
2024-09-30 230,700
2024-06-30 25,400
2024-06-30 63,900
2024-06-30 1,459,950
2024-03-31 7,400
2024-03-31 2,965,586
2024-03-31 19,200
2023-12-31 15,700
2023-12-31 14,300
2023-12-31 34,640
2023-09-30 19,400
2023-09-30 13,900
2023-09-30 75,742
2023-06-30 1,456
2023-06-30 19,200
2023-06-30 26,000
2023-03-31 392,065
2022-12-31 515,797
2022-06-30 38,810
2021-06-30 18,200
2021-03-31 32,621